Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor

Review

Multiple myeloma/hypercalcemia

Babatunde O Oyajobi

Arthritis Research & Therapy 2007, 9(Suppl 1):S4  doi:10.1186/ar2168

Article Metrics

7644
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 96 accesses
  • Last 365 days: 691 accesses
  • All time: 7644 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information